Subscribe for $2

Subscribe for 2 $

Financial Data API

Terminal Financial Data API

Biomea Fusion Aktie News & Pressemeldungen

Biomea Fusion Eulerpool News

12/17/2024, 5:37:12 PM

Biomea Fusion erntet Lob für bahnbrechende Diabetes-Studie

10/10/2024, 7:02:57 PM

Auf und Ab an den US-Börsen: Biomea Fusion im Aufwind, Rio Tinto setzt auf Zukauf

6/7/2024, 3:03:34 PM

US-Arbeitsmarktdaten sorgen für gemischte Signale an der Wall Street

1

1

Biomea Fusion Stock News

Biomea Fusion is being monitored by journalists and investors worldwide. We gather the latest Biomea Fusion news here.

December 17 ·
Yahoo
Why Is Diabetes-Drug Developer Biomea Fusion Stock Trading Lower On Tuesday?
December 17 ·
Yahoo
Biomea Fusion Announces Positive Topline Results from Ongoing Phase II COVALENT-111 Study in Patients with Type 2 Diabetes
December 17 ·
Yahoo
Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)
December 9 ·
Yahoo
Biomea Fusion Announces Preliminary Data from Ongoing COVALENT-103 Study of Investigational Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia
December 6 ·
Yahoo
Biomea Fusion to Host Conference Call to Present initial Clinical Data from Phase I COVALENT-103 Study of BMF-500, a Covalent FLT3 Inhibitor, in Relapsed or Refractory Acute Leukemia
November 18 ·
Yahoo
Late-Breaker Oral Presentation Showing New Analysis from the Escalation Portion of COVALENT-111 Presented at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2024)
November 13 ·
Yahoo
We're A Little Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate
November 3 ·
TipRanks
Short Report: Archer Aviation shorts at seven-week high
November 1 ·
Yahoo
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
October 31 ·
TipRanks
Scotiabank Sticks to Its Buy Rating for Biomea Fusion (BMEA)

1

2

1

2

Biomea Fusion Stock Press Releases

Biomea Fusion regularly publishes news on the company's website that are relevant for investors.

Access the world's leading financial data and tools

Subscribe for $2